Irinotecan [clinicaltrials_resource:e51064865358a8412329fc174471d012]
A Phase I Study of Irinotecan (CPT-11) Administered as a Prolonged Infusion in Adult Patients With Solid Tumors [clinicaltrials:NCT00001495]Irinotecan Plus Cyclosporine and Phenobarbital in Treating Patients With Solid Tumors or Lymphoma [clinicaltrials:NCT00002759]Irinotecan Plus ICI D1694 in Treating Patients With Advanced Solid Tumors [clinicaltrials:NCT00002902]clinicaltrials:NCT00002933Irinotecan and Paclitaxel in Treating Patients With Metastatic or Recurrent Cancer [clinicaltrials:NCT00002939]Irinotecan Plus Carmustine in Treating Patients With Recurrent Primary Malignant Glioma [clinicaltrials:NCT00002988]Cisplatin and Irinotecan in Treating Patients With Locally Advanced or Metastatic Esophageal or Gastric Cancer [clinicaltrials:NCT00003055]Irinotecan Plus Raltitrexed in Treating Patients With Refractory Solid Tumors [clinicaltrials:NCT00003109]Combination Chemotherapy Followed by Surgery in Treating Patients With Stage IIIA Non-small Cell Lung Cancer [clinicaltrials:NCT00003111]clinicaltrials:NCT00003134clinicaltrials:NCT00003137clinicaltrials:NCT00003225Irinotecan in Treating Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma [clinicaltrials:NCT00003245]Combination Chemotherapy in Treating Patients With Recurrent Metastatic Colorectal Cancer [clinicaltrials:NCT00003260]clinicaltrials:NCT00003276Irinotecan in Treating Patients With Recurrent Malignant Glioma [clinicaltrials:NCT00003301]Radiation Therapy Plus Irinotecan in Treating Patients With Colon Cancer [clinicaltrials:NCT00003344]Cisplatin Plus Irinotecan in Treating Patients With Ovarian, Fallopian Tube, or Peritoneal Cancer [clinicaltrials:NCT00003345]clinicaltrials:NCT00003351Irinotecan in Treating Patients With Solid Tumors or Lymphoma Who Have Abnormal Liver or Kidney Function or Who Have Received Radiation Therapy to the Pelvis [clinicaltrials:NCT00003368]Oxaliplatin Plus Irinotecan in Treating Patients With Metastatic Gastrointestinal Cancer [clinicaltrials:NCT00003427]Carmustine Wafers Plus Irinotecan in Treating Patients With Recurrent Supratentorial High Grade Gliomas [clinicaltrials:NCT00003463]Radiolabeled Monoclonal Antibody Therapy After Radiation Therapy in Treating Patients With Primary Brain Tumors [clinicaltrials:NCT00003484]Irinotecan in Treating Patients With Metastatic Colorectal Cancer [clinicaltrials:NCT00003544]clinicaltrials:NCT00003594Irinotecan in Treating Patients With Progressive or Recurrent Malignant Glioma [clinicaltrials:NCT00003616]Irinotecan Plus Mitomycin in Treating Patients With Advanced Solid Tumors [clinicaltrials:NCT00003710]Combination Chemotherapy in Treating Patients With Metastatic Solid Tumors [clinicaltrials:NCT00003711]Irinotecan in Treating Patients With Stage IV or Recurrent Soft Tissue Sarcoma [clinicaltrials:NCT00003719]Combination Chemotherapy in Treating Patients With Locally Advanced or Metastatic Solid Tumors [clinicaltrials:NCT00003742]clinicaltrials:NCT00003748Floxuridine, Dexamethasone, and Irinotecan After Surgery in Treating Patients With Liver Metastases From Colorectal Cancer [clinicaltrials:NCT00003753]Combination Chemotherapy in Treating Patients With Stage III Colon Cancer [clinicaltrials:NCT00003835]Irinotecan in Treating Patients With Colorectal Cancer [clinicaltrials:NCT00003843]Irinotecan and Capecitabine in Treating Patients With Solid Tumors [clinicaltrials:NCT00003867]clinicaltrials:NCT00003900clinicaltrials:NCT00003950Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Metastatic Rhabdomyosarcoma or Sarcoma [clinicaltrials:NCT00003955]Genetic Testing Plus Irinotecan in Treating Patients With Solid Tumors or Lymphoma [clinicaltrials:NCT00003970]Monoclonal Antibody Plus Chemotherapy in Treating Patients With Advanced Colorectal Cancer That Overexpresses HER2 [clinicaltrials:NCT00003995]
intervention browse [clinicaltrials_vocabulary:intervention-browse]
Irinotecan [clinicaltrials_resource:e51064865358a8412329fc174471d012]
Bio2RDF identifier
e51064865358a8412329fc174471d012
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:e51064865358a8412329fc174471d012
identifier
clinicaltrials_resource:e51064865358a8412329fc174471d012
title
Irinotecan
@en
type
label
Irinotecan [clinicaltrials_resource:e51064865358a8412329fc174471d012]
@en